wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q28075305-44A04DD3-FB8B-46B1-BA0F-A4A540ACD2B5
Q28075305-44A04DD3-FB8B-46B1-BA0F-A4A540ACD2B5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28075305-44A04DD3-FB8B-46B1-BA0F-A4A540ACD2B5
Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma
P2860
Q28075305-44A04DD3-FB8B-46B1-BA0F-A4A540ACD2B5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28075305-44A04DD3-FB8B-46B1-BA0F-A4A540ACD2B5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
eeeb87de18991b2147cb6c3bbd34f2c53b084099
P2860
Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: a propensity score matching study.